2018
DOI: 10.1186/s12876-018-0842-7
|View full text |Cite
|
Sign up to set email alerts
|

Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments

Abstract: BackgroundPrevious studies have indicated that bile acid is associated with progression of liver cirrhosis. However, the particular role of specific bile acid in the development of liver cirrhosis is not definite. The present study aims to identify the specific bile acid and explore its possible mechanisms in promoting liver cirrhosis.MethodsThirty two cirrhotic patients and 27 healthy volunteers were enrolled. Age, gender, Child-Pugh classification and serum of patients and volunteers were collected. Liquid c… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
52
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 74 publications
(54 citation statements)
references
References 32 publications
2
52
0
Order By: Relevance
“…Though the analyses above focused on BA pool size and FXR and FGFR activation in HSCs, it is important to note that various BA species have differential effects on HSCs. (31)(32)(33)(34) Of importance in this study, after treatment with CCl 4 , serum concentrations of T-CDCA and CDCA increased to a greater extent in KO mice and WT mice. Therefore, extent of FXR activation in HSCs after CCl 4 may be affected by both BA pool size and composition.…”
Section: Discussionmentioning
confidence: 71%
See 1 more Smart Citation
“…Though the analyses above focused on BA pool size and FXR and FGFR activation in HSCs, it is important to note that various BA species have differential effects on HSCs. (31)(32)(33)(34) Of importance in this study, after treatment with CCl 4 , serum concentrations of T-CDCA and CDCA increased to a greater extent in KO mice and WT mice. Therefore, extent of FXR activation in HSCs after CCl 4 may be affected by both BA pool size and composition.…”
Section: Discussionmentioning
confidence: 71%
“…Collagen levels and Col1α1 expression were inversely correlated with TBAP size and hepatic Shp expression in KO and TG mice. Though the analyses above focused on BA pool size and FXR and FGFR activation in HSCs, it is important to note that various BA species have differential effects on HSCs . Of importance in this study, after treatment with CCl 4 , serum concentrations of T‐CDCA and CDCA increased to a greater extent in KO mice and WT mice.…”
Section: Discussionmentioning
confidence: 89%
“…This was said to be due to increased synthesis. In addition, the promotion of cirrhosis progression by taurocholate was postulated to be due to stellate cell activation via the TLR4 pathway [132].…”
Section: Fibrosis and Cirrhosismentioning
confidence: 99%
“…These elevated metabolite levels are consistent with the fact that cAMP mediates the catecholaminergic control on heart rate and contractility; creatine and its degradation product creatinine are pivotal parts of the mitochondrial ATP shuttle; and L-carnitine is conjugated to fatty acids to enable their import into the mitochondria for beta-oxidation in cardiomyocytes Zaccolo, 2009;Zervou et al, 2016) . In contrast, and consistent with its distinct functions, the liver contained higher levels of taurocholic acid (liver bile salt), phenylpyruvic acid (phenylalanine metabolism restricted to liver and kidneys), phosphoenolpyruvic acid (gluconeogenesis), and riboflavin (vitamin storage) (Baker et al, 1964;Garibotto et al, 2002;Liu et al, 2018;Yang et al, 2009). Liver samples also contained higher levels of mannose, glucose-6-phosphate and galactonic acid, reflecting the differences in fuel utilization preferences between the heart (mostly fatty acids) and the liver (mix of glycolysis and fatty acid oxidation) (Rui, 2014;Stanley and Chandler, 2002;Wood et al, 1961).…”
Section: Discussionmentioning
confidence: 88%